biosyn Arzneimittel GmbH is a pharmaceutical and biotech company specializing in trace elements, particularly in high-dose selenium injections, and operates two unique GMP-based active ingredient manufacturing facilities.

biosyn Arzneimittel GmbH

biosyn Arzneimittel GmbH | 621 followers on LinkedIn. biosyn Arzneimittel GmbH is a pharmaceutical company promoting immune health in Germany&#39;s Pharmaland | We are research. We are biosyn, a health-driven biotech and pharmaceutical company.

The promotion of a healthy immune system is the elemental philosophy behind every product we develop.

CEO | General Manager | Entrepreneur | Strategic Transformation | Agile Execution Excellence | Go-to-Market Strategy | Business Development |…

Pascal Voltzenlugel

Director Sales at biosyn Arzneimittel GmbH

Dimitri Tarasyuk

Regional Business Head - Asia at Biosyn Arzneimittel GmbH, Stuttgart, Germany

Navjinder Singh Saini

Geschäftsleitung bei biosyn Arzneimittel GmbH

Dr. rer. nat. Thomas Stiefel

biosyn Arzneimittel GmbH is involved in the pharmaceutical and biotech sectors, specializing in trace elements, particularly high-dose selenium injections, and operates unique GMP-active ingredient manufacturing plants.

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 12, 2024 5:12 PM	302812f4
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 12, 2024 5:12 PM	f4b54aba
crunchbase trigger	general	Nov 12, 2024 5:12 PM	cd9dd817
crunchbase profile	general
li profile	general	Nov 12, 2024 5:12 PM	2d270c4b
translate crunchbase fundingrounds	general
peers	general	Nov 12, 2024 5:12 PM	9228d4e7
news basic	general	Nov 12, 2024 5:12 PM	0847f269
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

BIOS

DE:BIOSYN

biosyn Arzneimittel GmbH